Estrone sulfate sodium
Suppliers
Names
[ CAS No. ]:
438-67-5
[ Name ]:
Estrone sulfate sodium
[Synonym ]:
Estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-, sodium salt (1:1)
Sodium 17-oxoestra-1(10),2,4-trien-3-yl sulfate
Estrone 3-sulfate sodium salt
Estrone sodium sulfate
Estrone sulfate sodium
Estrone-3-sulfate sodium salt
estrone sodium sulphate
Sodium estrone 3-sulfate
Chemical & Physical Properties
[ Density]:
1.349 g/cm3
[ Melting Point ]:
258-260°C
[ Molecular Formula ]:
C18H21NaO5S
[ Molecular Weight ]:
372.41
[ Exact Mass ]:
372.100739
[ PSA ]:
91.88000
[ LogP ]:
4.03160
[ Storage condition ]:
-20°C
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- KG8775000
- CHEMICAL NAME :
- Estrone, hydrogen sulfate, sodium salt
- CAS REGISTRY NUMBER :
- 438-67-5
- LAST UPDATED :
- 199509
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C18-H22-O5-S.Na
- MOLECULAR WEIGHT :
- 373.45
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 504 ug/kg
- SEX/DURATION :
- female 9 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - menstrual cycle changes or disorders
- REFERENCE :
- JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 55,191,1979
Safety Information
[ Symbol ]:
GHS07, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H315-H319-H335-H350
[ Precautionary Statements ]:
P201-P261-P305 + P351 + P338-P308 + P313
[ Hazard Codes ]:
T: Toxic;
[ Risk Phrases ]:
R45-36/37/38
[ Safety Phrases ]:
S53-45-26
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
KG8775000
Precursor & DownStream
Precursor
DownStream
Articles
J. Pharm. Sci. 102(1) , 280-8, (2013)
We aimed to explore the major active components in grapefruit juice (GFJ), orange juice (OJ), and apple juice (AJ) that are responsible for OATP2B1-mediated drug interactions, by means of in vitro stu...
Drug Metab. Dispos. 43(2) , 284-8, (2015)
To predict transporter-mediated drug disposition using physiologically based pharmacokinetic models, one approach is to measure transport activity and relate it to protein expression levels in cell li...
J. Clin. Oncol. 32(28) , 3111-7, (2014)
Endogenous hormones are risk factors for postmenopausal breast cancer, and their measurement may improve our ability to identify high-risk women. Therefore, we evaluated whether inclusion of plasma es...